Skip to content

Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

Verification of Prognostic Risk Factors of Thrombohemorrhagic Complications in Early Follow-up Period in Recipients After Living Related Liver Transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06169592
Acronym
VORTAL
Enrollment
30
Registered
2023-12-13
Start date
2022-04-22
Completion date
2026-12-16
Last updated
2025-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cirrhosis, Liver Transplant; Complications

Brief summary

The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.

Interventions

PROCEDURELiver transplantation

Related transplantation of the right lobe of the liver

Sponsors

Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age over 18 years and up to 70 years; * Signed informed consent for inclusion to the study; * End stage liver cirrhosis.

Exclusion criteria

* Pregnancy; * Extrahepatic factors influencing systemic hemostasis; * Concomitant hematological diseases affecting the hemostatic system; * Severe concomitant disorders.

Design outcomes

Primary

MeasureTime frameDescription
Thrombosis of vascular anastomosis1 monthThrombosis of arterial or venous anastomosis after intervention

Secondary

MeasureTime frameDescription
Hemorrhagic complications1 monthAny hemorrhagic complications after intervention

Countries

Uzbekistan

Contacts

Primary ContactAzam Babadjanov, Professor
azambabadjanov@gmail.com+998901751703

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026